<DOC>
	<DOCNO>NCT01315912</DOCNO>
	<brief_summary>In prospective interventional study , 44 Clomiphene resistant infertile patient select Abolfazl Infertility Clinic Bushehr University Medical Sciences . Letrozole give orally dose 2.5mg , 5mg 7.5mg , respectively . If patient display response , dosage increase . The size follicle , endometrial thickness , estradiol , complication clinical pregnancy rate evaluate final outcome .</brief_summary>
	<brief_title>Dosage Optimization Letrozole Treatment</brief_title>
	<detailed_description>In prospective intervention , investigator study Abolfazle outpatient refer u Bushehr University Medical Sciences Iran January 1 , 2008 December 30 , 2010 . The study approve institutional Ethics Committee Bushehr University Medical Sciences patient require provide write informed consent study commenced.There 3 step investigator prescribe letrozole ( Femara , Novartis , Quebec , Canada ) . In case , daily administration begin 3rd day menstrual cycle 7th day ( total 5 day ) . In first step investigator prescribe letrozole dose 2.5 mg ( one tablet ) one two cycle accord patient 's response . Normal follicular size endometrial thickness consider 18-24 mm 6 mm respectively.1 If follicle deem acceptable , dose letrozole increase next cycle . At second third step investigator prescribe letrozole dose 5 mg daily 7.5 mg/day , respectively accord patient 's response , repeat dose . In current study investigator test hypothesis prescribe letrozole ovulation induction agent infertile woman would increase pregnancy rate , ovulation follicle number ( normal size range 18-24 mm ) , endometrial thickness ( normal thickness 6 mm ) considerable side effect patient . The primary outcome measure normal follicular size secondary outcome measure clinical current pregnancy rate . Clinical pregnancy consider presence gestational sac fetal heart activity . Letrozole tablet prescribe experienced nurse throughly explain method use patient . Sonography do experienced radiologist . The nurse prescribed letrozole patient university hospital laboratory 's technician know past medical history clomiphene resistance patient . The radiologist knowledge drug prescribe patient . Side effect complication Letrozole detail patient obstetrician . Statistical analysis perform Statistical Package Social Science version 11.5 window ( SPSS Inc. , Chicago . IL ) . The data analyze student 's t-test chi-squared test linear trend compare proportion . A P-value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>The study group consist polycystic ovarian syndrome ( PCOS ) patient diagnose accord Rotterdam criterion . The investigator define Clomiphene citrate ( Clomid , Iran hormone , Tehran , Iran ) resistance anovulation consumption 3 cycle cc 150 mg/day , determine serial estradiol monitoring sonography . Patients resistant Clomiphene citrate become candidate letrozole ( Femara , Novartis , Quebec , Canada ) consumption stepup protocol . Patients 18 39 year age , body mass index ( BMI ) &gt; 19 &lt; 30 kg/m2 day 3 folliclestimulating hormone ( FSH ) &lt; 12Miu/Ml . abnormal thyroid Function test hyperprolactinoma galactorrhea malefactor infertility tubal uterine cause infertility ( hysterosalpingography ) abnormal response progesterone challenge test imply endogenous estrogen production poor patient compliance complication treatment</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>clomiphene citrate</keyword>
	<keyword>infertility</keyword>
	<keyword>letrozole</keyword>
</DOC>